Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

Clinical trial NCT02479399 · COMPLETED

Trial details

NCT number: NCT02479399
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes

Start date: 2014-07-17
Primary completion: 2018-10-16
Enrollment: 11412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.